Search Results 121-130 of 16878 for Ulcerative+colitis

  1. A Study to Evaluate the Effectiveness and Safety of Risankizumab in Subjects with Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

    A Study to Evaluate the Effectiveness and Safety of Risankizumab in Subjects with Moderately-to-Severely Active Ulcerative Colitis. Print details. Share ...

  2. Olsalazine (oral route) - Mayo Clinic

    Olsalazine is used in patients who have had ulcerative colitis to prevent the condition from occurring again. It works inside the bowel by helping to reduce ...

  3. A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to evaluate the safety, tolerability and microbiome dynamics of SER-287 in subjects with mild-to-moderate ulcerative colitis.

  4. Examining clinical and genetic factors that impact response to anti-TNF agents in patients with IBD

    ... for treating ulcerative colitis, anti-tumor necrosis factor (TNF) agents have provided a potent tool for managing inflammatory bowel disease (IBD) symptoms.

  5. A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis - Mayo Clinic

    Ozanimod will be administered orally to pediatric participants with moderate to severe active Ulcerative Colitis who have had an inadequate response to ...

  6. A Study to Evaluate the Safety and Effectiveness of Ustekinumab Induction and Maintenance Therapy in Participants with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    ... Ulcerative Colitis. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview.

  7. A Study to Assess Effectiveness and Safety of SER‑287 in Adults With Active Mild-to-Moderate Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to assess the effectiveness and safety of SER-287 in adults with active mild-to-moderate ulcerative colitis. Participation ...

  8. Upadacitinib (oral route) - Mayo Clinic

    Kidney disease, severe—Use with caution in patients with atopic dermatitis, Crohn's disease, or ulcerative colitis. The effects may be increased because of ...

  9. Diarrhea - Mayo Clinic

    Ulcerative colitis · Ulcerative colitis flare-ups: 5 tips to manage them · Vesicoureteral reflux · How irritable bowel syndrome affects you · Vitamin deficiency ...

  10. Etrasimod (oral route) - Mayo Clinic

    Description. Etrasimod is used to treat moderate to severe active ulcerative colitis. This medicine is available only with your doctor's prescription. This ...